Indications, Safety and Warnings for the Ellipse ICD | Abbott
CARDIOVASCULAR
hamburger

Indications, Safety & Warnings

Ellipse™ ICD
Dual-Chamber

CD2411-36Q

Rx Only

Brief Summary: Prior to using these devices, please review the User’s Manual for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.

Indications: The devices are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. AF Suppression™ pacing is indicated for suppression of paroxysmal or persistent atrial fibrillation in patients with the above ICD indication and sinus node dysfunction.

Contraindications: Contraindications for use of the pulse generator system include ventricular tachyarrhythmias resulting from transient or correctable factors such as drug toxicity, electrolyte imbalance or acute myocardial infarction.

Adverse Events: Possible adverse events (in alphabetical order) associated with the system, include, but are not limited to the following:

  • Acceleration of arrhythmias (caused by device)
  • Air embolism
  • Allergic reaction
  • Bleeding
  • Cardiac tamponade
  • Chronic nerve damage
  • Death
  • Erosion
  • Exacerbation of heart failure
  • Excessive fibrotic tissue growth
  • Extracardiac stimulation (phrenic nerve, diaphragm, chest wall)
  • Extrusion
  • Fluid accumulation
  • Formation of hematomas or cysts
  • Inappropriate shocks
  • Infection
  • Keloid formation
  • Lead abrasion and discontinuity
  • Lead migration/dislodgment
  • Myocardial damage
  • Pneumothorax
  • Shunting current or insulating myocardium during defibrillation with internal or external paddles
  • Potential mortality due to inability to defibrillate or pace
  • Thromboemboli
  • Venous occlusion
  • Venous or cardiac perforation.

Patients susceptible to frequent shocks despite antiarrhythmic medical management may develop psychological intolerance to an ICD or CRT-D system that may include the following:

  • Dependency
  • Depression
  • Fear of premature battery depletion
  • Fear of shocking while conscious
  • Fear of losing shock capability
  • Imagined shocking (phantom shock)

Refer to the User’s Manual for detailed indications, contraindications, warnings, precautions and potential adverse events.

Ellipse™ ICD
Single-Chamber

CD1411-36Q

Rx Only

Brief Summary: Prior to using these devices, please review the User’s Manual for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.

Indications: The devices are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. AF Suppression™ pacing is indicated for suppression of paroxysmal or persistent atrial fibrillation in patients with the above ICD indication and sinus node dysfunction.

Contraindications: Contraindications for use of the pulse generator system include ventricular tachyarrhythmias resulting from transient or correctable factors such as drug toxicity, electrolyte imbalance or acute myocardial infarction.

Adverse Events: Possible adverse events (in alphabetical order) associated with the system, include, but are not limited to the following:

  • Acceleration of arrhythmias (caused by device)
  • Air embolism
  • Allergic reaction
  • Bleeding
  • Cardiac tamponade
  • Chronic nerve damage
  • Death
  • Erosion
  • Exacerbation of heart failure
  • Excessive fibrotic tissue growth
  • Extracardiac stimulation (phrenic nerve, diaphragm, chest wall)
  • Extrusion
  • Fluid accumulation
  • Formation of hematomas or cysts
  • Inappropriate shocks
  • Infection
  • Keloid formation
  • Lead abrasion and discontinuity
  • Lead migration/dislodgment
  • Myocardial damage
  • Pneumothorax
  • Shunting current or insulating myocardium during defibrillation with internal or external paddles
  • Potential mortality due to inability to defibrillate or pace
  • Thromboemboli
  • Venous occlusion
  • Venous or cardiac perforation.

Patients susceptible to frequent shocks despite antiarrhythmic medical management may develop psychological intolerance to an ICD or CRT-D system that may include the following:

  • Dependency
  • Depression
  • Fear of premature battery depletion
  • Fear of shocking while conscious
  • Fear of losing shock capability
  • Imagined shocking (phantom shock)

Refer to the User’s Manual for detailed indications, contraindications, warnings, precautions and potential adverse events.

MAT-2009641 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.